Follow The Filings

GERN Geron

Geron earnings company data as of 8:30 AM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -0.01 0.00 Beat
Rev $60.4M $60.2M In line -0.3%

Insider trades

Open-market buys and sales by GERN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GERN insider trades
  • $11K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Harout Semerjian CEO
    Buy
    — 53,500 shares New stake
    Traded Nov 13 Filed Nov 16
  2. Timothy Williams EVP and Chief Legal Officer
    Buy
    $11K 12,000 shares at $0.9400 New stake
    Traded Nov 16 Filed Nov 16

Also filed in the last 12 months, not counted as buying or selling: 4 stock grants, 1 option exercise, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 5.02
SCHEDULE 13G —
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 1.01
8-K 2.05
10-Q

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf